Should you buy MAZE stock?
Last updated:
Based on market data through , StockInvest.us rates Maze Therapeutics, Inc. Common Stock (MAZE) as a Sell Candidate with a technical score of -1.93 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Down 0.18%
- 3-month trend forecast Up 14.75%
- +102.5% price growth over the last year
- High gross margin of 92.0%
- Low bankruptcy risk (Altman Z-Score: 9.80)
Maze Therapeutics, Inc. Common Stock stock price down 4.78% on Monday
(Market data through Aug 10, 2026)
The Maze Therapeutics, Inc. Common Stock stock price fell by -4.78% on the last day (Monday, 10th Aug 2026) from $28.65 to $27.28. During the last trading day the stock fluctuated 8.43% from a day low at $26.58 to a day high of $28.82. The price has risen in 6 of the last 10 days but is still down by -4.91% for this period. Volume has increased on the last day by 194 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 669 thousand shares were bought and sold for approximately $18.26 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $26.51 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 14.75% during the next 3 months and, with a 90% probability hold a price between $30.42 and $39.66 at the end of this 3-month period.
MAZE Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Maze Therapeutics, Inc. Common Stock stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $27.73 and $28.72. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -16.93%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Maze Therapeutics, Inc. Common Stock stock
Maze Therapeutics, Inc. Common Stock finds support from accumulated volume at $27.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.24 between high and low, or 8.43%. For the last week, the stock has had daily average volatility of 6.47%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (MAZE) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Maze Therapeutics, Inc. Common Stock to open at $27.56, and during the day (based on 14 day Average True Range), to move between $26.50 and $28.06, which gives a possible trading interval of +/-$1.56 (+/-5.88%) up or down from last closing price. If Maze Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 5.88% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $27.02 (0.95%) than the resistance at $28.43 (4.22%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Maze Therapeutics, Inc. Common Stock stock A Buy?
The Maze Therapeutics, Inc. Common Stock stock holds several negative signals and despite the positive trend, we believe Maze Therapeutics, Inc. Common Stock will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score:
-1.925
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $27.56 ( 1.03%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
MAZE Performance
Trading levels for MAZE
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.80 | 9.24% |
| R2 | 28.94 | 6.10% |
| R1 | 28.42 | 4.16% |
| Price | 27.28 | |
| S1 | 26.70 | -2.11% |
| S2 | 26.18 | -4.05% |
| S3 | 25.32 | -7.18% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 31.99 | 17.27% |
| R2 | 29.81 | 9.27% |
| R1 | 28.43 | 4.22% |
| Price | 27.28 | |
| S1 | 27.02 | -0.95% |
| S2 | 25.68 | -5.87% |
| S3 | 24.27 | -11.03% |
FAQ
Click here for our free guide on how to buy Maze Therapeutics, Inc. Common Stock Stock.
Buy MAZE